ArticleHepatology international2026

Comment on "Hepatic arterial infusion chemotherapy combined with lenvatinib and programmed death receptor-1 inhibitors for hepatocellular carcinoma with Vp4 portal vein tumor thrombus: a multicenter, propensity-score matching comparative study".

Yuanbin Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.